CYTOKINE-GUIDED PARACRINE REGULATION OF LEYDIG CELLS
细胞因子引导间质细胞的旁分泌调节
基本信息
- 批准号:2200513
- 负责人:
- 金额:$ 8.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-12-01 至 1997-11-30
- 项目状态:已结题
- 来源:
- 关键词:Leydig cells antibody cell cell interaction cyclic AMP cytokine endotoxins gene expression gonadotropins hormone regulation /control mechanism hydroxysteroid dehydrogenases immunocytochemistry immunoregulation in situ hybridization injection /infusion interleukin 1 laboratory mouse lipopolysaccharides macrophage messenger RNA paracrine radioimmunoassay steroid hormone biosynthesis tumor necrosis factor alpha
项目摘要
The long range objectives of this research are to understand the role of
testicular interstitial macrophages (TIMs) in the paracrine regulation
of Leydig cell steroidogenic function and to elucidate the molecular
mechanisms through which TIMs-secreted cytokines regulate steroid hormone
biosynthesis.
We have determined that immune-activation of mice by injection with
bacterial endotoxin, lipopolysaccharide (LPS), results in a marked, but
reversible, inhibition of Leydig cell steroidogenesis. Data are
presented which demonstrate that LPS stimulates TIMs to express cytokine
mRNAs and that cytokines inhibit Leydig cell function in vitro. Together
these observations suggest that TIMs might exert a cytokine-guided
paracrine regulatory influence on Leydig cell function. The studies
proposed in this application will characterize the interaction of TIMs
and Leydig cells in situ in control and immune-activated mice by
utilizing immunocytochemical and in situ hybridization technologies.
These studies will also examine the mechanisms through which cytokines
inhibit Leydig cell steroidogenesis utilizing molecular biological and
biochemical technologies. The specific aims of this project are: (1)
To examine the interaction of TIMs and Leydig cells in situ in control
and immune-activated mice; (2) To determine what factors are responsible
for the inhibition of Leydig cell steroidogenesis; and (3) To determine
the mechanisms through which cytokines inhibit Leydig cell
steroidogenesis.
Infection and chronic inflammation, conditions associated with increased
cytokine production by activated macrophages, often result in impaired
male reproductive function. Testosterone production by Leydig cells is
essential for spermatogenesis. TIMs and Leydig cells are closely
associated in the testis. This suggests that TIMs might exert a
cytokine-guided paracrine regulatory influence over Leydig cells. The
studies proposed in this application will test the hypothesis that
immune-activation of TIMs results in the secretion of cytokines which
inhibit Leydig cell steroidogenesis.
本研究的长期目标是了解
旁分泌调节中的睾丸间质巨噬细胞(TIM)
Leydig细胞类固醇生成功能的研究,并阐明
TIMs分泌的细胞因子调节类固醇激素的机制
生物合成
我们已经确定,通过注射
细菌内毒素,脂多糖(LPS),导致一个显着的,但
可逆的,抑制Leydig细胞类固醇生成。 数据
显示LPS刺激TIM表达细胞因子,
mRNA和细胞因子在体外抑制Leydig细胞功能。 一起
这些观察结果表明,TIM可能会发挥一种神经递质引导的
旁分泌对间质细胞功能的调节作用。 研究
本申请中提出的方法将表征TIM的相互作用
和Leydig细胞原位在对照组和免疫激活的小鼠,
利用免疫细胞化学和原位杂交技术。
这些研究还将检查细胞因子
利用分子生物学方法抑制Leydig细胞类固醇生成,
生物化学技术 该项目的具体目标是:(1)
在对照组中原位检测TIM和Leydig细胞的相互作用
和免疫激活小鼠;(2)确定哪些因素是负责
用于抑制Leydig细胞类固醇生成;和(3)确定
细胞因子抑制Leydig细胞的机制
类固醇生成
感染和慢性炎症,与增加的
由活化的巨噬细胞产生的细胞因子,通常导致受损的
男性生殖功能 睾丸间质细胞产生睾酮是
对精子生成至关重要。 TIM和Leydig细胞密切相关,
与睾丸有关。 这表明TIM可能会发挥作用,
尼古丁引导的旁分泌调节对间质细胞的影响。 的
在本申请中提出的研究将检验假设,
TIM的免疫激活导致细胞因子的分泌,
抑制Leydig细胞类固醇生成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DALE B HALES其他文献
DALE B HALES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DALE B HALES', 18)}}的其他基金
Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer
亚麻籽治疗卵巢癌的疗效
- 批准号:
8187471 - 财政年份:2011
- 资助金额:
$ 8.61万 - 项目类别:
Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer
亚麻籽治疗卵巢癌的疗效
- 批准号:
8510582 - 财政年份:2011
- 资助金额:
$ 8.61万 - 项目类别:
Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer
亚麻籽治疗卵巢癌的疗效
- 批准号:
8687600 - 财政年份:2011
- 资助金额:
$ 8.61万 - 项目类别:
Fish oil for the prevention and treatment of ovarian cancer
鱼油预防和治疗卵巢癌
- 批准号:
8203398 - 财政年份:2011
- 资助金额:
$ 8.61万 - 项目类别:
Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer
亚麻籽治疗卵巢癌的疗效
- 批准号:
8300791 - 财政年份:2011
- 资助金额:
$ 8.61万 - 项目类别:
Fish oil for the prevention and treatment of ovarian cancer
鱼油预防和治疗卵巢癌
- 批准号:
8320111 - 财政年份:2011
- 资助金额:
$ 8.61万 - 项目类别:
Dietary Intervention in the Gallus Domesticus Model of Ovarian Cancer
卵巢癌鸡内金模型的饮食干预
- 批准号:
7618836 - 财政年份:2008
- 资助金额:
$ 8.61万 - 项目类别:
Dietary Intervention in the Gallus Domesticus Model of Ovarian Cancer
卵巢癌鸡内金模型的饮食干预
- 批准号:
7473514 - 财政年份:2008
- 资助金额:
$ 8.61万 - 项目类别:
Therapeutic Efficacy of Flax Seed in the Prevention of Ovarian Cancer
亚麻籽预防卵巢癌的疗效
- 批准号:
7385503 - 财政年份:2007
- 资助金额:
$ 8.61万 - 项目类别:
Therapeutic Efficacy of Flax Seed in the Prevention of Ovarian Cancer
亚麻籽预防卵巢癌的疗效
- 批准号:
7504027 - 财政年份:2007
- 资助金额:
$ 8.61万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 8.61万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 8.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 8.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)